MedInformatix Previews Mobile App to Help Practices Market, Manage Relationships & Generate New Referrals

Los Angeles, CA – (July 24, 2019) ) Health IT innovator MedInformatix announced today it will launch a marketing referral app to help radiology and other medical practices generate new leads from referring physicians. The new app will feature a seamless integration with the MedInformatix RIS and EHR, and provide real-time access to a wide range of data analytics and notation systems to marketers and physician liaisons at the practice level. The app was previewed at the recent 2019 Radiology Business Management Association SPARK gathering in Miami Beach, the foremost seminar for radiology business marketers.

“We are continually looking to introduce new technologies to help practices be more efficient in today’s rapidly changing and competitive healthcare landscape,” said Pat McGonigle, President and CEO of MedInformatix. “Our new marketing referral app delivers on that promise and, once implemented, will enable practices to more easily engage with referring physician groups so they can manage these relationships more intuitively and generate new leads.”

The app will provide marketers the ability to chart useful pre- and post-marketing outreach notes on a certain referring group so a history can be developed to manage the relationship as it unfolds. Other features include an expense functionality to help monitor and meet marketing budgets for groups who track the amount spent per doctor or referral group. The app can also be used to calculate the approximate cost of referral, similar to the cost of customer acquisition used by sales professionals, so the practice can determine a return on its marketing investment.

The app’s seamless integration with the MedInformatix RIS and EHR platform reduces duplication of efforts and provides the marketing team real-time access to view and update referral data, whether they are in the office or traveling or working remotely. It also allows everyone at the practice to view and make decisions using the same real-time data and information. “It’s sort of like a CRM system on the go and brings a whole new level of productivity and accountability to the practice,” added Michele Jones, Chief Marketing Officer at MedInformatix.

MedInformatix has been testing a prototype of the app with select clients, incorporating input into the final phases of the functionality in advance of an expected general availability in early 2020.

About MedInformatix:

MedInformatix is delivering tomorrow’s healthcare information technology today via innovative enterprise practice management, electronic health records and radiology information systems solutions. The company’s signature software solution, MedInformatix V7.6, is customizable across multiple medical specialties and modalities, helping practices of all sizes achieve optimal data and workflow efficiency.For more information visit www.medinformatix.com.

MedInformatix, 11/21/2013, MedInformatix v7.6, Criteria Certified: 170.314(a)(1‐15); 170.314(b)(1‐5, 7);170.314(c)(1‐3); 170.314(d)(1‐9); 170.314(e)(1‐3); 170.314(f)(1‐3); 170.314(g)(2‐4), Certification ID Number: 11212013‐1814‐6, Clinical Quality Measures Certified: CMS002v3; CMS022v2; CMS050v2; CMS052v2; CMS056v2; CMS061v3; CMS062v2; CMS064v3; CMS065v3; CMS066v2; CMS068v3; CMS069v2; CMS074v3; CMS075v2; CMS077v2; CMS082v1; CMS090v3; CMS117v2; CMS122v2; CMS123v2; CMS124v2; CMS125v2; CMS126v2; CMS127v2; CMS128v2; CMS129v3; CMS130v2; CMS131v2; CMS132v2; CMS133v2; CMS134v2; CMS135v2; CMS136v3; CMS137v2; CMS138v2; CMS139v2; CMS140v2; CMS141v3; CMS142v2; CMS143v2; CMS144v2; CMS145v2; CMS146v2; CMS147v2; CMS148v2; CMS149v2; CMS153v2; CMS154v2; CMS155v2; CMS156v2; CMS157v2; CMS158v2; CMS159v2; CMS160v2; CMS161v2; CMS163v2; CMS164v2; CMS165v2; CMS166v3; CMS167v2; CMS169v2; CMS177v2; CMS179v2; CMS182v3. Additional software used: Alere Analytics™, Updox Direct 2014, NetTime; MedlinePlus Connect, NewCropRX.

This certified product may require a one-time license and implementation and training fee and ongoing annual maintenance and support. Incremental cost that an eligible provider would incur to implement this certified product in order to meet meaningful use objectives and measures may include a one-time cost to establish interfaces for outbound lab orders, inbound lab results, HIE’s and registries, ongoing monthly support cost on applicable interfaces, ongoing subscription fee for Third Party Software used to meet Meaningful Use (including, but not limited to: Alere Analytics™, Updox Direct 2014, and NewCropRX.